Related Experiment Video
Updated: Jul 29, 2025
06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
2.4K
Vulnerability in Biomedical Research: A Historical Reflection and Practical Implications for HIV Cure-Related
Emily Rao1, Jeff Taylor2,3,4, Andy Kaytes2
1School of Medicine, University of California San Diego (UCSD), San Diego, California, USA.
AIDS Research and Human Retroviruses
|May 25, 2023
Summary
Vulnerability in bioethics requires careful consideration, especially for people with HIV (PWH) in research. Their historical activism and unique perspectives challenge standard vulnerability definitions, emphasizing voluntary participation.
Area of Science:
- Bioethics
- Medical Research Ethics
- Public Health
Background:
- The concept of vulnerability in bioethics emerged in 1979 with the Belmont Report, necessitating special protections for certain populations in human participant research.
- The history of HIV treatment development has significantly influenced bioethical debates on vulnerability, with patient activism challenging established research protocols.
- Contemporary HIV cure research highlights the need to re-evaluate population-based vulnerability assessments, considering participant motivations and community perspectives.
Purpose of the Study:
- To analyze the evolving concept of vulnerability in bioethics, particularly in the context of HIV research.
- To examine how the activism of people with HIV has shaped ethical considerations in clinical trials.
- To discuss the implications of community perspectives on vulnerability in current HIV cure research.
Main Methods:
- Historical analysis of bioethical literature and patient advocacy movements.
- Case study examination of HIV treatment and cure research ethics.
- Review of regulatory frameworks and ethical guidelines concerning vulnerable populations.
Main Results:
- Patient empowerment movements, such as The Denver Principles, have historically challenged and reshaped research ethics protocols.
- The perspectives of people with HIV (PWH) and affected communities are crucial in determining benefit/risk profiles in clinical trials.
- Current HIV cure research indicates that community motivations and objectives challenge simplistic, population-based definitions of vulnerability.
Conclusions:
- While regulatory frameworks are necessary, they risk overshadowing the fundamental value of voluntary participation in research.
- The unique history and lived experiences of PWH must be central to ethical considerations in HIV cure research.
- A nuanced understanding of vulnerability, informed by community engagement, is essential for ethical and effective biomedical research.
More Related Videos
23:56Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
16.8K
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
31.7K
Related Concept Videos
01:10Retrovirus Life Cycles
46.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.3K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
01:56Ethics in Research
23.1K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.1K
01:29Microorganisms in Medicine and Therapeutics
77
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
77
00:36Viral Mutations
32.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.6K
01:29Pulmonary Tuberculosis I
293
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
293